Customer Letters
Date Sort descending | ||
---|---|---|
CL_2022-01.pdf | INFORMATION ONLY |
|
CL_2022-02.pdf | INFORMATION ONLY Customer Letter 2022-02 (PDF) | Cutaquig Extended Shelf Life - Customer Letter (PDF) |
|
CL_2022-03.pdf | INFORMATION ONLY |
|
CL_2022-04.pdf | INFORMATION ONLY |
|
CL_2022-05.pdf | INFORMATION ONLY Customer Letter 2022-05 (PDF) | Takeda - Introducing a new format of CUVITRU® 10 g/50ml in Canada (PDF) |
|
CL_2022-06.pdf | INFORMATION ONLY Customer Letter 2022-06 (PDF) | 2021 Recombinant RFP FAQ: Process, Results, and Product Availability (PDF) |
|
CL_2022-07.pdf | INFORMATION ONLY Customer Letter 2022-07 (PDF) | National Recipient Advisory Committee Recommendation (PDF) |
|
CL_2022-08.pdf | INFORMATION ONLY |
|
CL_2022-09.pdf | INFORMATION ONLY |
|
CL_2022-10.pdf | INFORMATION ONLY Customer Letter 2022-10 (PDF) | Esperoct Welcome Letter (PDF) | Zonovate Welcome Letter (PDF) | Zonovate Product Profile (PDF) | Esperoct Product Profile (PDF) | F801219 Sample (PDF) |
|
CL_2022-11.pdf | ACTION REQUIRED |
|
CL_2022-12.pdf | INFORMATION ONLY Customer Letter 2022-12 (PDF) | ADYNOVATE® changes and timelines(PDF) |
|
CL_2022-13.pdf | INFORMATION ONLY |
|
CL_2022-14.pdf | INFORMATION ONLY |
|
CL_2022-15.pdf | INFORMATION ONLY Customer Letter 2022-15 (PDF) | Procare Patient Advisory Letter (PDF) | Procare HCP Advisory Letter (PDF) |
|
CL_2022-16.pdf | ACTION REQUIRED |
|
CL_2022-17.pdf | INFORMATION ONLY |
|
CL_2022-18.pdf | ACTION REQUIRED |
|
CL_2022-19.pdf | INFORMATION ONLY |
|
CL_2022-20.pdf | INFORMATION ONLY Customer Letter 2022-20 (PDF) | Kamada Customer Letter (PDF) |
|
CL_2022-21.pdf | ACTION REQUIRED Customer Letter 2022-21 (PDF) | HyperHEP B® - Product Update (PDF) |
|
CL_2022-22.pdf | INFORMATION ONLY |
|
CL_2022-23.pdf | INFORMATION ONLY Customer Letter 2022-23 (PDF) | Product Monograph Including Patient Medication Information (PDF) | Patient Medication Information Leaflet (PDF) |
|
CL_2022-24.pdf | INFORMATION ONLY Customer Letter 2022-24 (PDF) | Kamada Hospital Letter (PDF) |
|
CL_2022-25.pdf | INFORMATION ONLY |
|
CL_2022-26.pdf | INFORMATION ONLY |
|
CL_2022-27.pdf | INFORMATION ONLY |
|
CL_2022-28.pdf | INFORMATION ONLY Customer Letter 2022-28 (PDF) | Octaplasma Blood Bank Communication (PDF) |
|
CL_2022-29.pdf | INFORMATION ONLY Customer Letter 2022-29 (PDF) | Terumo notification letter (PDF) |
|
CL_2022-30.pdf | ACTION REQUIRED |
|
CL_2022-31.pdf | ACTION REQUIRED |
|
CL_2022-32.pdf | INFORMATION ONLY |
|
CL_2022-33.pdf | INFORMATION ONLY |
|
CL_2022-34.pdf | ACTION REQUIRED |
|
CL_2022-35.pdf | INFORMATION ONLY |
|
CL_2022-36.pdf | INFORMATION ONLY Customer Letter 2022-36 (PDF) | Factor XI Packaging Change (PDF) |
|
CL_2022-37.pdf | INFORMATION ONLY |